Tag: substance

Apr 27, 2026

• substance
• antiparasitic
• investigational-oncology
• evidence-preclinical-only
• do-not-use-for-cancer-without-trial

Apr 27, 2026

• substance
• cholestatic-pruritus
• PBC
• ASBT-inhibitor
• FDA-2026

Apr 26, 2026

• substance
• GLP-1
• amylin
• incretin
• obesity
• type-2-diabetes
• body-composition
• wearable-confounder
• investigational

Apr 26, 2026

• substance
• basal-insulin
• type2-diabetes
• metabolic
• weekly-injectable
• cgm

Apr 26, 2026

• substance
• GLP-1
• incretin
• obesity
• metabolic-health
• type-2-diabetes
• body-composition
• wearable-confounder
• FDA-approved

Apr 25, 2026

• substance
• obesity
• GLP-1
• body-composition
• lean-mass
• myostatin
• activin
• phase-2
• investigational

Apr 25, 2026

• substance
• peptide
• dual-agonist
• glp1
• glucagon
• obesity
• type-2-diabetes
• mash
• phase-3
• investigational

Apr 24, 2026

• substance
• peptide
• glp1
• glucagon
• dual-agonist
• obesity
• mash
• t2d
• phase-3
• vitals-phase-3
• in-review